A Pilot Study of the Effects of Niacin Administration on Free Fatty Acid and Growth Hormone Concentrations in Children with Obesity

Overview

Journal Pediatr Obes

Specialties Endocrinology
Pediatrics

Date 2016 Sep 23

PMID 27654882

Citations 4

Authors

O A Galescu

M K Crocker

A M Altschul

S E Marwitz

S M Brady

J A Yanovski

Affiliations

Soon will be listed here.

Abstract

Context: Children with obesity have low spontaneous growth hormone (GH) secretion. High circulating free fatty acid (FFA) concentration is believed to inhibit GH secretion in those with obesity. In adults, lipolytic inhibition with niacin lowers FFA and increases GH, but there are no prior studies in children with obesity.

Objective: The objective of the study was to determine the dose and frequency of niacin administration required to lower FFA and stimulate GH in children with obesity.

Design: Dose-finding study of nondiabetic children ages 6-12 years with body mass index (BMI) ≥ 95th percentile given niacin 250 mg q2h × 3 doses (n = 2), 500 mg q2h × 3 doses (n = 5) or 500 mg q1h × 4 doses (n = 5).

Participants: Eight boys and four girls (age 9.7 ± 1.8 years; BMI 26.4 ± 3.1 kg m ; BMIz 2.2 ± .25) were studied.

Main Outcome: Percentage of serum FFA values that were below 0.2 mEq L . GH, insulin and glucose were also measured serially.

Results: FFA decreased as the dose and frequency of niacin increased (p = .01). Niacin 500 mg q1h 4 doses suppressed FFA < 0.2 mEq L and significantly increased GH (p = .04). Adverse effects were flushing/warmth (100%), tingling (60%) and GI complaints (20-40%).

Conclusions: Niacin 500 mg q1h significantly lowered serum FFA and increased GH. These pilot data suggest that high FFA is an important suppressor of GH secretion in children with obesity.

Citing Articles

Water-Soluble Vitamins: Hypo- and Hypervitaminosis in Pediatric Population.

Paparella R, Panvino F, Leonardi L, Pucarelli I, Menghi M, Micangeli G Pharmaceutics. 2025; 17(1).

PMID: 39861765 PMC: 11768360. DOI: 10.3390/pharmaceutics17010118.

Niacin intake and mortality (total and cardiovascular disease) in patients with cardiovascular disease: Insights from NHANES 2003-2018.

Yang R, Zhu M, Fan S, Zhang J Nutr J. 2024; 23(1):123.

PMID: 39415265 PMC: 11481813. DOI: 10.1186/s12937-024-01027-y.

Primary cilia formation requires the Leigh syndrome-associated mitochondrial protein NDUFAF2.

Lo C, Liu Z, Chen S, Lin F, Berneshawi A, Yu C J Clin Invest. 2024; 134(13).

PMID: 38949024 PMC: 11213510. DOI: 10.1172/JCI175560.

Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes.

Sobczak A, Blindauer C, Stewart A Nutrients. 2019; 11(9).

PMID: 31466350 PMC: 6770316. DOI: 10.3390/nu11092022.

Association study between growth hormone receptor ( ) gene polymorphisms and obesity in Korean population.

Yang S J Exerc Rehabil. 2017; 12(6):632-636.

PMID: 28119888 PMC: 5227328. DOI: 10.12965//jer.1632844.422.

References

Barb C, Kraeling R, Rampacek G . Glucose and free fatty acid modulation of growth hormone and luteinizing hormone secretion by cultured porcine pituitary cells. J Anim Sci. 1995; 73(5):1416-23. DOI: 10.2527/1995.7351416x. View

Gianotti L, Fassino S, Daga G, Lanfranco F, De Bacco C, Ramunni J . Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. Clin Endocrinol (Oxf). 2000; 52(6):713-20. DOI: 10.1046/j.1365-2265.2000.00990.x. View

Kasa-Vubu J, Barkan A, Olton P, Meckmongkol T, Carlson N, Foster C . Incomplete modified fast in obese early pubertal girls leads to an increase in 24-hour growth hormone concentration and a lessening of the circadian pattern in leptin. J Clin Endocrinol Metab. 2002; 87(4):1885-93. DOI: 10.1210/jcem.87.4.8250. View

Assan R, TCHOBROUTSKY G . Serial plasma growth hormone levels in 33 cases of severe diabetic ketoacidosis--effects of sodium nicotinate. Horm Metab Res. 1972; 4(5):317-21. DOI: 10.1055/s-0028-1094023. View

Zhang Y, Schmidt R, Foxworthy P, Emkey R, Oler J, Large T . Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A. Biochem Biophys Res Commun. 2005; 334(2):729-32. DOI: 10.1016/j.bbrc.2005.06.141. View

Heptulla R, Smitten A, Teague B, Tamborlane W, Ma Y, Caprio S . Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity. J Clin Endocrinol Metab. 2001; 86(1):90-6. DOI: 10.1210/jcem.86.1.7136. View

Valera Mora M, Manco M, Capristo E, Guidone C, Iaconelli A, Gniuli D . Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery. Obesity (Silver Spring). 2007; 15(8):2012-8. DOI: 10.1038/oby.2007.240. View

Kok P, Buijs M, Kok S, Van Ierssel I, Frolich M, Roelfsema F . Acipimox enhances spontaneous growth hormone secretion in obese women. Am J Physiol Regul Integr Comp Physiol. 2003; 286(4):R693-8. DOI: 10.1152/ajpregu.00595.2003. View

Irie M, Tsushima T, Sakuma M . Effect of nicotinic acid administaation on plasma HGH, FFA and glucose in obese subjects and in hypopituitary patients. Metabolism. 1970; 19(11):972-9. DOI: 10.1016/0026-0495(70)90043-0. View

10.

Savastano S, Angrisani L, Di Somma C, Rota F, Savanelli M, Cascella T . Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. Obes Surg. 2009; 20(2):211-20. DOI: 10.1007/s11695-009-9926-3. View

11.

Quabbe H, Luyckx A, Lage M, Schwarz C . Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). J Clin Endocrinol Metab. 1983; 57(2):410-4. DOI: 10.1210/jcem-57-2-410. View

12.

Cordido F, Alvarez-Castro P, Luisa Isidro M, Casanueva F, Dieguez C . Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol. 2003; 149(2):117-22. DOI: 10.1530/eje.0.1490117. View

13.

Xu R, Wang Q, Yan M, Hernandez M, Gong C, Boon W . Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes. Endocrinology. 2002; 143(12):4609-19. DOI: 10.1210/en.2002-220506. View

14.

Uccella R, Morenghi R, Agosti C, Saponati G . Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate). Artery. 1983; 11(5):400-12. View

15.

Argente J, Caballo N, Barrios V, Pozo J, Munoz M, Chowen J . Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab. 1997; 82(7):2076-83. DOI: 10.1210/jcem.82.7.4089. View

16.

Oliver S, Rosa J, Minh T, Pontello A, Flores R, Barnett M . Dose-dependent relationship between severity of pediatric obesity and blunting of the growth hormone response to exercise. J Appl Physiol (1985). 2009; 108(1):21-7. PMC: 2885072. DOI: 10.1152/japplphysiol.00589.2009. View

17.

Stokes K, Tyler C, Gilbert K . The growth hormone response to repeated bouts of sprint exercise with and without suppression of lipolysis in men. J Appl Physiol (1985). 2008; 104(3):724-8. DOI: 10.1152/japplphysiol.00534.2007. View

18.

Alvarez C, Mallo F, Burguera B, Cacicedo L, Dieguez C, Casanueva F . Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. Neuroendocrinology. 1991; 53(2):185-9. DOI: 10.1159/000125716. View

19.

Sazonov V, Maccubbin D, Sisk C, Canner P . Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Int J Clin Pract. 2013; 67(4):297-302. DOI: 10.1111/ijcp.12089. View

20.

Pineda J, Dieguez C, Casanueva F, Martul P . Decreased growth hormone response to dexamethasone stimulation test in obese children. Acta Paediatr. 1994; 83(1):103-5. DOI: 10.1111/j.1651-2227.1994.tb12963.x. View